相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis
Zhuqing Shi et al.
PROSTATE (2022)
Prediction of clinically significant prostate cancer using polygenic risk models in Asians
Sang Hun Song et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2022)
Germline pathogenic variants in unselected Korean men with prostate cancer
Min-Kyung So et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2022)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
David Conti et al.
NATURE GENETICS (2021)
A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
Sang Hun Song et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2021)
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
Yukihide Momozawa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort
Yudai Ishiyama et al.
PLOS ONE (2020)
The influence of BRCA2 mutation on localized prostate cancer
Renea A. Taylor et al.
NATURE REVIEWS UROLOGY (2019)
Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
H. Ballentine Carter et al.
EUROPEAN UROLOGY (2019)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
Martina Mijuskovic et al.
BRITISH JOURNAL OF CANCER (2018)
Epidemiology of prostate cancer in Asian countries
Takahiro Kimura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
Rong Na et al.
EUROPEAN UROLOGY (2017)
Evaluation of the changing landscape of prostate cancer diagnosis and management from 2005 to 2016
Kirsten R. Carlaw et al.
PROSTATE INTERNATIONAL (2017)
InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines
Quan Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases
Rong Na et al.
ASIAN JOURNAL OF ANDROLOGY (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers
E. Castro et al.
ANNALS OF ONCOLOGY (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
LUMPY: a probabilistic framework for structural variant discovery
Ryan M. Layer et al.
GENOME BIOLOGY (2014)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Pablo Cingolani et al.
FLY (2012)
CNVnator: An approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing
Alexej Abyzov et al.
GENOME RESEARCH (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Number of prostate cancer risk alleles may identify possibly 'insignificant' disease
Brian T. Helfand et al.
BJU INTERNATIONAL (2010)
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling
M. Pensabene et al.
ANNALS OF ONCOLOGY (2009)